Kai Wermker
Osnabrueck, NI 49076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Relative tumour budding (TB rel) predicts occult nodal metastasis, aggressiveness and survival in oral squamous cell carcinoma.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
Published: March 18, 2026
De-escalation strategies in the treatment of oral squamous cell carcinoma: A cross-sectional study in oral and maxillofacial surgery in Germany, Austria, and Switzerland.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
Published: October 27, 2025
Next-Generation Sequencing Reveals the Potential Role of RET Protooncogene in Metastasis Progression in Medullary Thyroid Cancer.
Journal: Current issues in molecular biology
Published: June 03, 2025
Tumor budding predicts lymph node metastasis in squamous cell carcinoma of the lip.
Journal: Head & face medicine
Published: April 28, 2025
Progression-, aggression-, survival and outcome characteristics in Merkel cell carcinomas in 176 patients.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
Published: April 01, 2025
Impact of postoperative dairy consumption on oral wound healing: critical analysis from a prospective, randomized and controlled trial.
Journal: Head & face medicine
Published: September 19, 2024
Microvascular reconstruction in oral and maxillofacial surgery: a Europe-wide data collection.
Journal: Oral and maxillofacial surgery
Published: July 14, 2024
Patient management with Head and Neck tumors-A nationwide data collection in oral and maxillofacial surgery.
Journal: Clinical oral investigations
Published: June 12, 2024
New Tumor Budding Evaluation in Head and Neck Squamous Cell Carcinomas.
Journal: Cancers
Published: December 28, 2023
IMP3 Expression as a Potential Tumour Marker in High-Risk Localisations of Cutaneous Squamous Cell Carcinoma: IMP3 in Metastatic cSCC.
Journal: Cancers
Published: June 29, 2023
Last Updated: 09/26/2026